Pernille Lassen

Summary

Affiliation: Aarhus University Hospital
Country: Denmark

Publications

  1. ncbi Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Noerrebrogade 44, DK 8000 Aarhus C, Denmark
    J Clin Oncol 27:1992-8. 2009
  2. ncbi HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Noerrebrogade 44, DK 8000 Aarhus C, Denmark
    Radiother Oncol 94:30-5. 2010
  3. ncbi The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, DK 8000 Aarhus C, Denmark
    Radiother Oncol 95:371-80. 2010
  4. ncbi The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 100:49-55. 2011
  5. ncbi Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck
    Kasper Toustrup
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Arahus C, Denmark
    Radiother Oncol 102:122-9. 2012
  6. ncbi Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials
    Camilla Molich Hoff
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 50:1006-14. 2011

Detail Information

Publications6

  1. ncbi Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Noerrebrogade 44, DK 8000 Aarhus C, Denmark
    J Clin Oncol 27:1992-8. 2009
    ....
  2. ncbi HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Noerrebrogade 44, DK 8000 Aarhus C, Denmark
    Radiother Oncol 94:30-5. 2010
    ..Using p16-status as a retrospective stratification parameter, we aimed to assess the influence of p16-expression on the response to nimorazole in HNSCC...
  3. ncbi The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, DK 8000 Aarhus C, Denmark
    Radiother Oncol 95:371-80. 2010
    ..This review provides a summary of the current understanding of the role of HPV in head and neck cancer with specific focus on the viral impact on radiotherapy outcome of HNSCC...
  4. ncbi The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 100:49-55. 2011
    ..We aimed to assess the influence of tumour HPV-status, expressed by p16, on the response to accelerated fractionated radiotherapy in HNSCC through evaluation of the DAHANCA 6&7 trial...
  5. ncbi Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck
    Kasper Toustrup
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Arahus C, Denmark
    Radiother Oncol 102:122-9. 2012
    ..To validate the predictive impact of a hypoxia gene expression classifier in identifying patients with head and neck squamous cell carcinoma (HNSCC) having benefit from hypoxic modification of radiotherapy...
  6. ncbi Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials
    Camilla Molich Hoff
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 50:1006-14. 2011
    ..Aim of the current analysis was to gain additional power by adding patients from the continued subrandomization in the DAHANCA 7 trial, now including a total of almost 1200 patients...